Clinical Trial Update: Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating epoetin alfa for chemotherapy-related anemia in women with stage I-III breast cancer; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Breast Cancer

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)
• Epogen (epoetin alfa)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Anemia, Breast Cancer | Phase 4 | Status: COMPLETED